We found that the DNA methylation levels of CD146 in cancer tissues were significantly lower than that in normal samples, indicating that a low level of promoter methylation status of CD146 is responsible for the overexpression of CD146 in ccRCC. This evidence concerns the gene MCAM and cancer.